Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

10.7%

11 terminated/withdrawn out of 103 trials

Success Rate

73.2%

-13.4% vs industry average

Late-Stage Pipeline

10%

10 trials in Phase 3/4

Results Transparency

0%

0 of 30 completed trials have results

Key Signals

17 recruiting9 terminated

Enrollment reporting

Analytics

N/A
36(43.4%)
Phase 2
35(42.2%)
Phase 3
5(6.0%)
Phase 4
5(6.0%)
Phase 2/3
1(1.2%)
Phase 1
1(1.2%)
83Total
N/A(36)
Phase 2(35)
Phase 3(5)
Phase 4(5)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (103)

Showing 20 of 103 trials
NCT06638931Phase 2Active Not Recruiting

Agnostic Therapy in Rare Solid Tumors

Role: lead

NCT04522570Not ApplicableCompleted

Thermal Ablation of Cervical Metastases From Thyroid Carcinoma

Role: lead

NCT07632638Not ApplicableActive Not Recruiting

Safety and Performance Evaluation of the RonovoTM Robotic Surgical Platform in Oncological Procedures

Role: lead

NCT06887621Phase 2Active Not Recruiting

Efficacy of Adding Oral Amisulpride to Dual Prophylaxis for Postoperative Nausea and Vomiting in Patients at High Risk for Nausea and Vomiting Undergoing Gynecological Surgery

Role: lead

NCT07316686Phase 1Recruiting

Phase I Study of Docetaxel and 177-Lutetium-PSMA-I&T in First-Line Treatment for Patients With Metastatic Castration-Resistant Prostate Adenocarcinoma

Role: lead

NCT07738094Not ApplicableRecruiting

Cold and NSAID Trial for Prevention of Post-ERCP Pancreatitis

Role: lead

NCT05354778Not ApplicableCompleted

HYDROcortisone Versus Placebo for Severe HospItal-acquired Pneumonia in Intensive Care Patients: the HYDRO-SHIP Study

Role: collaborator

NCT04498260Phase 4Completed

Intralesional Steroid Injection Versus Oral Prednisolone in Prevention of Esophageal Stricture

Role: lead

NCT06070376Not ApplicableRecruiting

Comparative Study Between (FC-SEMS) and (PC-SEMS) in the Palliation of Dysphagia Due to Malignant Neoplasm of Esophagus.

Role: lead

NCT06077981Not ApplicableRecruiting

Comparison of 0.4% Hyaluronic Acid Solution Versus Hydroxyethylamide Solution in Submucosal Endoscopic Resections

Role: lead

NCT07066046Not ApplicableRecruiting

Artificial Intelligence-assisted Colonoscopy in the Detection and Characterization of Colorectal Lesions

Role: lead

NCT07644455Not ApplicableNot Yet Recruiting

Percutaneous Biopsy After Neoadjuvant Chemotherapy.

Role: lead

NCT07463092Not ApplicableRecruiting

Creatine Supplementation and Resistance Training to Improve Sarcopenia Parameters in Patients With Prostate Cancer After Androgen Deprivation Therapy

Role: collaborator

NCT07600515Not Yet Recruiting

Evaluation of Persistent Infection by Oncogenic Human Papillomavirus (HPV) in Patients Treated for Cervical Carcinoma and Its Relation to Prognostic Factors

Role: lead

NCT05622136Phase 2Active Not Recruiting

Dose-escalation of Regorafenib in Advanced Hepatocellular Carcinoma

Role: lead

NCT06435286Phase 2Recruiting

Effectiveness and Performance of an Optical Biopsy Technology for Esophageal Cancer in Brazil and the United States

Role: collaborator

NCT07432360Recruiting

Detecting Clinically Significant Prostate Cancer With Advanced MRI Protocols and Extensive Histopathology

Role: collaborator

NCT07376317Phase 2Active Not Recruiting

Optimization of Immunotherapy Treatment for Advanced Melanoma in the Context of the Public Brazilian Health System (OTIMAS)

Role: lead

NCT06640283Phase 2Recruiting

Dynamic ctDNA Assessment in Cervical and Anal Canal Tumors: Optimizing Follow-up and Clinical Outcomes

Role: lead

NCT06978673Not ApplicableNot Yet Recruiting

Neurolytic Block Techniques In Abdominal Visceral Cancer Pain

Role: lead